SCHEMBL6906667

SCHEMBL6906667

CC(C)c1cc(C(C)C)c(O[Zr](Cl)(Cl)Oc2c(C(C)C)cc(C(C)C)cc2P(c2ccccc2)c2ccccc2)c(P(c2ccccc2)c2ccccc2)c1

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 1/20 0.32
FABP3 P05413 1/20 0.31
FABP4 P15090 1/20 0.31
GLRA1 P23415 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6906670 0.80 ROCK2 (0.32) ROCK2FABP3FABP4
Hydrochloric Acid SCHEMBL6906661 0.80 ROCK2 (0.32) ROCK2FABP3FABP4
SCHEMBL6910098 0.70
SCHEMBL29735852 0.70 ROCK2 (0.40) ROCK2FABP3FABP4
SCHEMBL645251 0.70 ROCK2 (0.40) ROCK2FABP3FABP4
Hydrochloric Acid SCHEMBL6910099 0.69 ROCK2 (0.32) ROCK2FABP3FABP4
SCHEMBL6909605 0.69 DRD1 (0.30)
SCHEMBL6902166 0.69 DRD1 (0.33)
SCHEMBL6909648 0.68 GABRA1 (0.33) FABP3FABP4
SCHEMBL6905286 0.68 CYP1A2 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6730626-B2 TRANSITION METAL DERIVATIVE CAN REACT TO FORM AN IONIC COMPLEX WITH THE ALUMINOXANE IDEMITSU PETROCHEMICAL CO., LTD. (JP) 2004-05-04 US disclosed
EP-1323723-A1 TRANSITION METAL COMPOUNDS, POLYMERIZATION CATALYSTS FOR OLEFINS, OLEFIN POLYMERS AND PROCESS FOR THEIR PRODUCTION IDEMITSU PETROCHEMICAL CO., LTD. (JP) 2003-07-02 EP disclosed
US-20020193536-A1 Transition metal compound, polymerization catalysts for olefins, olefin polymers and process for their production IDEMITSU KOSAN CO. LTD. (JP) 2002-12-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020193536-A1 Transition metal compound, polymerization catalysts for olefins, olefin polymers and process for their production CCNE2, PYM1, AP1M1 ROCK2 1243/4885FABP3 4363/4885FABP4 2931/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.